Hutch News

Hutch News

Stories tagged 'CMV'

Adam Geballe elected AAAS Fellow

Hutch virologist honored for revealing key players in molecular ‘arms race’ between viruses and hosts

Nov. 20, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Adam Geballe elected AAAS Fellow for pinpointing key players in molecular 'arms race' between viruses and human hosts

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

March 3, 2016

Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care; Hutch study finds CMV viral load can act as surrogate endpoint for clinical trials; A new target for Tumor Paint: BLZ-100 lights up head and neck cancers; Dr. Stephen Tapscott appointed to NIAMS advisory council

View story >

New vaccine may prevent cytomegalovirus infection

Vaccine and Infectious Disease Institute researchers co-author study on vaccine with potential to prevent the most common virus transmitted by a pregnant woman to her unborn child

March 23, 2009

A new vaccine that has the potential to be the first to prevent maternal and congenital cytomegalovirus (CMV) infection was detailed in a study published in the March 19 edition of the New England Journal of Medicine. Dr. Larry Corey, co-director of the Hutchinson Center’s Vaccine and Infectious Disease Institute, and Dr. Meei-li Huang, of VIDI and a research scientist in the Virology Division at the University of Washington and an affiliate member in VIDI, were co-authors of the paper with colleagues at the University of Alabama at Birmingham, who led the study.

View story >


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.